Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.
about
Insights from 100 Years of Research with Probiotic E. ColiTherapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility.Bacterial proteins and peptides in cancer therapy: today and tomorrowFrom promotion to management: the wide impact of bacteria on cancer and its treatmentPotent and tumor specific: arming bacteria with therapeutic proteins.Engineering of bacterial strains and their products for cancer therapy.Murine solid tumours as a novel model to study bacterial biofilm formation in vivo.Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth.Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats.E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy.Characterization of a Lactococcus lactis promoter for heterologous protein production.A repetitive mutation and selection system for bacterial evolution to increase the specific affinity to pancreatic cancer cells.
P2860
Q28079219-504DBDB6-2999-4ABC-BC39-1E5E09CEB2E6Q33829542-8C9F4A89-1BB5-4AE8-A789-3B1C0511D98CQ34075830-323DCDF0-34E5-4201-8615-801F8F2386B3Q34263890-847110AC-ABB9-4A2D-AB76-6D0838B37D45Q35579375-E766250F-9C87-4C8A-93D5-BD5C0A09271AQ38104247-0C47B931-F484-4B40-8D26-A30E40C85D1EQ38203911-D8A49D32-B52D-4033-B213-2658B9E49D09Q38957782-B4DD92C0-0C0E-4D8C-A1DD-3F26885F7C78Q40163572-D2F3ACE7-82E6-4D51-A61D-AB5871E3E9B0Q41573303-63C37442-E1EF-4A8F-81D8-9663E12E17CEQ46299094-FF8C4DFE-9877-45AE-9B7C-3EC75A7FABEDQ48595604-B448035E-6264-40CA-849D-A7F59D3C9906Q51074757-5AE88F27-0C10-41F0-AF84-DB973A5FAC47Q52647653-1389DBA5-116F-4C05-BAE8-6E0991D498F1Q52654965-9423C4A0-B1EF-4D31-8282-6F01A1980362Q55119902-9B164370-0273-43CC-9B34-CDB340D5CB95
P2860
Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@ast
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@en
type
label
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@ast
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@en
prefLabel
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@ast
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@en
P2093
P2860
P356
P1476
Escherichia coli Nissle 1917 t ...... expression of azurin protein.
@en
P2093
Xiangli Zhang
Xuezhi Ding
Youming Zhang
Yunlei Zhang
P2860
P304
P356
10.1128/AEM.01390-12
P407
P577
2012-08-24T00:00:00Z